Search
for
Sort by
Research 301–330 of 779
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Pharmacotherapy of alopecia areata
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Hair Follicle Reconstruction and Stem Cells
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Research Progress on the Application of Stem Cells in Hair Regeneration
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- New Treatments for Hair Loss
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Ritlecitinib: First Approval
- The role of lymphocytes in the development and treatment of alopecia areata
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis